Join Now

Yearly Archives: 2020

Clene Nanomedicine, Inc. Completes Enrollment in Rescue-ALS Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead Nanocatalytic Therapeutic, CNM-Au8

By admin | Published September 11, 2020

Clene Nanomedicine, Inc., (“Clene”) a clinical-stage biopharmaceutical company and its Australian subsidiary, Clene Australia Pty Ltd., on Tuesday announced the completion of patient enrollment in its RESCUE-ALS Phase 2 study. The multi-center study is designed to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of CNM-Au8 in early symptomatic ALS patients. The objective of this study […]

Posted in BioUtah News, Life Sciences Industry News | Leave a comment

Inherent Biosciences Wins $256K NSF Grant to predict COVID-19 infection severity and treatment response

By admin | Published September 11, 2020

Inherent Biosciences, a biotechnology company headquartered in Salt Lake City has announced a $255,959 award from the National Science Foundation (NSF) to study epigenetic biomarkers to predict patient response to COVID-19. The SBIR Phase I project aims to develop an onsite, clinical test to screen incoming patients potentially infected with COVID-19. The test would predict […]

Posted in BioUtah News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | Leave a comment

Utah Leads Together Accountability Framework

By admin | Published September 11, 2020

This Utah Leads Together Accountability Framework presents Utah’s strategic, data-driven, and concentrated effort to protect the lives and livelihoods of all Utahns. The framework includes a clear mission, two major goals, six supporting objectives, and a variety of lead measures and strategies. A scorecard of measurable targets motivates progress. Together with a refined accountability structure, […]

Posted in COVID-19 Updates | Leave a comment

Bayer Collaborates with Recursion to Strengthen Digital Drug Discovery and Advance New Therapies for Fibrotic Diseases

By admin | Published September 11, 2020

By Chris Gibson, PhD via Recursion – Drug discovery partnership and equity investment led by Leaps by Bayer in Series D financing round – Digitally-powered drug discovery to address fibrotic diseases with previously undiscovered mechanisms and to deliver novel therapies to patients faster Berlin, Germany and Salt Lake City, USA, September 9, 2020 – Bayer and […]

Posted in Industry News, Life Sciences Industry News | Leave a comment

HHS Move Upends FDA Role in Laboratory-Developed Test Regulation

By admin | Published August 28, 2020

By Adam Bonislawski for GenomeWeb NEW YORK – In a surprise move, the US Department of Health and Human Services said on Wednesday that it had determined the Food and Drug Administration would not require premarket review of laboratory-developed tests without notice-and-comment rulemaking. The announcement, which took many in the lab industry aback, appeared to […]

Posted in COVID-19 Updates, HHS/FDA & Other Regulatory | Leave a comment

Clene Nanomedicine Raises Series D Financing of $42.5 Million

By admin | Published August 28, 2020

SALT LAKE CITY, August 26, 2020 – Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced that it has secured $42.5 million in a Series D financing. The round was led by SymBiosis II, LLC, a biotech-focused investment vehicle. Participants in the round included existing investors, as well as new institutional investors from South Korea […]

Posted in Policy News | Leave a comment

HHS Determines FDA Can’t Regulate Lab-Developed Tests Without Formal Rulemaking

By Denise Bell | Published August 21, 2020

HHS said yesterday that it has determined that the FDA will not require premarket review of laboratory-developed tests (LDTs) without notice-and-comment rulemaking. This means that the FDA cannot expand its authority over LDTs through guidance and other informal issuances. As reported by Genome Web, it also means that laboratories will be able to “offer LDTs […]

Posted in Policy News | Leave a comment

BioUtah and Utah Biotech/Biopharma Companies Raise Concerns About Impact of Trump’s “Most-Favored-Nation” Drug Pricing Order on Innovation

By admin | Published August 19, 2020

BioUtah, along with 10 Utah biotech and biopharma companies, have sent letters to Utah’s U.S. Senators and Representatives urging opposition to the President’s directive to impose “most-favored nation” pricing on Medicare Part B drugs. The letter notes that if the executive order moves forward, investment dollars for Utah’s smaller drug discovery companies could dry up […]

Posted in Industry News, Policy News | Leave a comment

Recursion and University of Utah Launch Altitude Lab, Largest Life Sciences Incubator in Utah

By Denise Bell | Published August 14, 2020

On August 11, Altitude Lab, founded by BioUtah member Recursion and the University of Utah’s Center for Technology & Venture Commercialization (TVC),  announced its first resident companies and opened applications for its unique collaborative facility and program. The incubator, a state-of-the-art 14,500 square foot lab facility, will offer resident companies workshops, mentoring, and non-dilutive funding […]

Posted in Policy News | Leave a comment

2020 IPO Comeback Webcast Series from PwC

By admin | Published August 13, 2020

After IPO issuances came to a near-halt in late Q1 and early Q2, the window reopened wide this summer, when much-needed liquidity infused the markets and led to one of the strongest months for IPOs in 13 years. Join us for a two-part executive webcast series on the novel challenges of capital raising during a […]

Posted in Events | Leave a comment

COVID-19 Grant Relief Program Updates as of 8/12/2020 9:20 am

By admin | Published August 13, 2020

Shop In Utah: $35M (+ $10M added from ComRent) Opened Monday, July 27 – closed August 7, 2020, at 1:30 p.m. Shop in Utah number of applications received: 872 Shop in Utah total award amount requested: $42,344,434 Shop in Utah number of awards: 653 Shop in Utah total award amount: $26,790,444 Average award amount: $41,023 […]

Posted in Funding | Leave a comment

BioUtah Statement on Launch of Altitude Lab, Largest Life Sciences Incubator in Utah

By admin | Published August 12, 2020

Recursion and University of Utah found incubator to propel new generation of life sciences in the region August 12, 2020 04:18 PM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–BioUtah President and CEO, Kelvyn Cullimore, issued the following statement following the announcement of the opening of Altitude Lab. “This is truly a life sciences milestone in […]

Posted in BioUtah News, Industry News, Life Sciences Industry News | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members